| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.005 |